A.C.I. is a furniture maker in Izegem. Private Limited, started on 2 September 1996, 1 establishment.

What is the address of A.C.I.?

The registered office of A.C.I. is located at Lodewijk de Raetlaan 16, 8870 Izegem.

Is A.C.I. still active?

Yes. According to the CBE (29 October 2026) A.C.I. is active, legal situation “Normale toestand”, started on 2 September 1996.

Is A.C.I. registered on Peppol?

Yes, A.C.I. is registered on the Peppol network with ID 0208:0458634212.

What is the enterprise number of A.C.I.?

The enterprise number of A.C.I. is BE0458634212.

When was A.C.I. founded?

A.C.I. was founded on 2 September 1996.

Who are the directors of A.C.I.?

According to the 2025 annual accounts, the directors of A.C.I. are: 4CC BV, 4 GC SARL naar Luxemburgs recht.

Is A.C.I. a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 2 September 1996; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did A.C.I. make in 2025?

A.C.I. recorded a loss after taxes of € 519,747 in financial year 2025.

What is the revenue of A.C.I.?

As a small company, A.C.I. is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 1,982,069.

How much does an employee at A.C.I. earn?

The average wage cost per full-time employee at A.C.I. was € 64,100 in 2025: staff costs of € 2 million for 31.3 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does A.C.I. have?

According to the 2025 annual accounts, A.C.I. has 31.3 full-time equivalents (FTE).

Does A.C.I. have a website?

Yes, A.C.I. has a website at meditech-pharma.com.

A.C.I. (Private Limited) - Izegem - BE0458634212

Dossier A.C.I., printed on 29 October 2026 from databakkes.be/en/0458634212/a-c-i. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

A.C.I. from Izegem, company number BE0458634212, closed financial year 2025 with a result of € -519,747 after tax. For that financial year A.C.I. recorded a gross margin of € 2 million and equity of € 4.3 million. Compared with financial year 2024, the result moved from € 136,891 to € -519,747. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What it is worth Healthy

€ 4.3 million

▼ 11% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -519,747

▼ still € 136,891 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 776,559

▲ 284% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 2.7 million.

People and assets in 2025

Full-time equivalents

31.3

▼ 0.8 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 2 million

▲ 4% vs 2024

€ 64,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 144,421

▼ 21% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1.1 million

▼ 19% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 268,495

▲ 62% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 2,464,101 Gross margin 2022: € 2,464,101 First fiscal year in the series	€ 2,585,621 Gross margin 2023: € 2,585,621 ▲ 5% vs 2022 (€ 2,464,101) Favourable step	€ 2,467,965 Gross margin 2024: € 2,467,965 ▼ 5% vs 2023 (€ 2,585,621) Unfavourable step	€ 1,982,069 Gross margin 2025: € 1,982,069 ▼ 20% vs 2024 (€ 2,467,965) Unfavourable step	▼ 20%
Profit after taxes	€ 361,419 Profit after taxes 2022: € 361,419 First fiscal year in the series	€ 254,217 Profit after taxes 2023: € 254,217 ▼ 30% vs 2022 (€ 361,419) Unfavourable step	€ 136,891 Profit after taxes 2024: € 136,891 ▼ 46% vs 2023 (€ 254,217) Unfavourable step	€ -519,747 Profit after taxes 2025: € -519,747 ▼ € 656,638 vs 2024 (€ 136,891) Unfavourable step	▼ € 656,638
Equity	€ 4,450,301 Equity 2022: € 4,450,301 First fiscal year in the series	€ 4,704,519 Equity 2023: € 4,704,519 ▲ 6% vs 2022 (€ 4,450,301) Favourable step	€ 4,841,409 Equity 2024: € 4,841,409 ▲ 3% vs 2023 (€ 4,704,519) Favourable step	€ 4,321,662 Equity 2025: € 4,321,662 ▼ 11% vs 2024 (€ 4,841,409) Unfavourable step	▼ 11%
Total debts	€ 3,506,408 Total debts 2022: € 3,506,408 First fiscal year in the series	€ 2,829,898 Total debts 2023: € 2,829,898 ▼ 19% vs 2022 (€ 3,506,408) Favourable step	€ 1,972,226 Total debts 2024: € 1,972,226 ▼ 30% vs 2023 (€ 2,829,898) Favourable step	€ 1,707,470 Total debts 2025: € 1,707,470 ▼ 13% vs 2024 (€ 1,972,226) Favourable step	▼ 13%
Cash	€ 680,832 Cash 2022: € 680,832 First fiscal year in the series	€ 341,598 Cash 2023: € 341,598 ▼ 50% vs 2022 (€ 680,832) Unfavourable step	€ 202,225 Cash 2024: € 202,225 ▼ 41% vs 2023 (€ 341,598) Unfavourable step	€ 776,559 Cash 2025: € 776,559 ▲ 284% vs 2024 (€ 202,225) Favourable step	▲ 284%
Land & buildings	€ 994,158 Land & buildings 2022: € 994,158 First fiscal year in the series	€ 867,885 Land & buildings 2023: € 867,885 ▼ 13% vs 2022 (€ 994,158) Unchanged	€ 742,353 Land & buildings 2024: € 742,353 ▼ 14% vs 2023 (€ 867,885) Unchanged	€ 866,847 Land & buildings 2025: € 866,847 ▲ 17% vs 2024 (€ 742,353) Unchanged	▲ 17%
Retained profit	€ 2,785,159 Retained profit 2022: € 2,785,159 First fiscal year in the series	€ 3,039,377 Retained profit 2023: € 3,039,377 ▲ 9% vs 2022 (€ 2,785,159) Favourable step	€ 3,176,267 Retained profit 2024: € 3,176,267 ▲ 5% vs 2023 (€ 3,039,377) Favourable step	€ 2,656,520 Retained profit 2025: € 2,656,520 ▼ 16% vs 2024 (€ 3,176,267) Unfavourable step	▼ 16%
Balance sheet total	€ 7,960,210 Balance sheet total 2022: € 7,960,210 First fiscal year in the series	€ 7,537,567 Balance sheet total 2023: € 7,537,567 ▼ 5% vs 2022 (€ 7,960,210) Unchanged	€ 6,816,470 Balance sheet total 2024: € 6,816,470 ▼ 10% vs 2023 (€ 7,537,567) Unchanged	€ 6,031,684 Balance sheet total 2025: € 6,031,684 ▼ 12% vs 2024 (€ 6,816,470) Unchanged	▼ 12%
Employees (FTE)	33 Employees (FTE) 2022: 33 First fiscal year in the series	34.4 Employees (FTE) 2023: 34.4 ▲ 1.4 vs 2022 (33) Unchanged	32.1 Employees (FTE) 2024: 32.1 ▼ 2.3 vs 2023 (34.4) Unchanged	31.3 Employees (FTE) 2025: 31.3 ▼ 0.8 vs 2024 (32.1) Unchanged	▼ 0.8

Key figures of A.C.I., fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to A.C.I.?

What happened at A.C.I. in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 31, 2026 New annual accounts for financial year 2025: loss of € 519,747 (▼ € 656,638 vs 2024). filed late Source: NBB ↗
2025 4 GC SARL naar Luxemburgs recht became a director. NBB
Sep 5, 1996 New establishment in Izegem. KBO
Sep 2, 1996 Start of the company according to the CBE. KBO

In short

From € 361,419 profit in 2022 to € 519,747 loss in 2025.

Paid € 296,490 in corporate taxes since 2022.

Best year ever: 2022, with € 361,419 profit.

On average € 63,300 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

ECHOFIN 100%

The stake of ECHOFIN comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

A.C.I.

Behind A.C.I. are 4CC BV and 4 GC SARL naar Luxemburgs recht. The shares are held by ECHOFIN (100%).

Directors

According to the 2025 annual accounts

4CC BV

Managing director · represented by Els Vandecappelle

Also active at: CLEMENT PHARMA, O.C.I., ECHOFIN, R.C.I., A.C.N.

4 GC SARL naar Luxemburgs recht

Managing director · represented by Jan Clement

Also active at: CLEMENT PHARMA, O.C.I., ECHOFIN

since 2025

Shareholders

ECHOFIN

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Lodewijk de Raetlaan 16

8870 Izegem

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.

All companies at this address →

CLEMENT PHARMA same network

€ 1.1 million gross margin · 2025

O.C.I. same network

€ 534,350 gross margin · 2025

ECHOFIN same network

€ 2.3 million revenue · 2025

R.C.I. same network

€ 3 million gross margin · 2025

BTWE OCF

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS meditech-pharma.com

Canonical: https://www.meditech-pharma.com/

Technologies

Alpine.jsFont AwesomeGoogle Tag ManagerNginxiubenda

Hosting & Email

Email provider

Microsoft 365

Hosting

COMBELL-AS, BE

Domain

meditech-pharma.com

Registered

2004-08-25

Registrar

Combell NV

Expires

2026-08-25

Website info

HTTPS Ja

Languages DE, EN, ES, FR, NL

Features

Webshop Ads

Security

✓ HTTPS

✓ SPF

✓ DMARC

Network

✓ IPv6

Details

Company number

0458.634.212

VAT number

BE 0458.634.212

Registered office

Lodewijk de Raetlaan 16, 8870 Izegem

Names & denominations

A.C.I.

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

2 September 1996

Peppol

Active · Active since 9 Dec 2025

Contact

meditech-pharma.com +3292966221

Activities · NACE

Vervaardiging van kantoor- en winkelmeubelen

Vervaardiging van kantoor-, winkel- en ateliermeubelen, overwegend van andere materialen dan metaal

Algemene bouw van andere niet-residentiële gebouwen

View on CBE Public ↗ Annual accounts (NBB) ↗

A.C.I.

Financials

What happened to A.C.I.?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Website

Technologies

Hosting & Email

Domain

Website info

Features

Security

Network

Details

Frequently asked questions